Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 15 of 15

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Genotype-Phenotype Correlation in Inherited Retinal Diseases Caused By Biallelic CEP290 Variations

Birgit Lorenz; Ute Schneider; Hanno J Bolz; Christoph Friedburg; Monika Andrassi-Darida; Markus N Preising

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4515.

ARVO Annual Meeting Abstract July 2019

Autohaemotherapy based on gelsolin (GSN) enrichment supports corneal wound closure and has an anti-inflammatory effect on the ocular surface

Jessica Feldt; Martin Schicht; Fabian Garreis; Jessica Welss; Ulrich Schneider; Friedrich P Paulsen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5089.

ARVO Annual Meeting Abstract March 2012

Quantitative Assessment of the Effect of ICG-assisted Chromovitrectomy on Macular function

Alexandra Goz; Tatjana Josifova; Ulrike Schneider; Paul B. Henrich

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2642.

ARVO Annual Meeting Abstract April 2010

Evaluation of Retreatment Indications in a Randomized, Double-Masked Study Comparing Lucentis® Monotherapy and Combination Therapy With PDT in Neovascular AMD

K. B. Hatz; U. Schneider; P. B. Henrich; B. Braun; S. Sacu; G. Fuchsjaeger-Mayrl; C. Pruente

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2054.

ARVO Annual Meeting Abstract April 2009

Microperimetric Assessment of Macular Holes Before and After Surgery

P. W. Hasler; B. Braun; B. Sander; U. Schneider; M. Larsen; C. Pruente

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):760.

ARVO Annual Meeting Abstract April 2009

Evaluation of Re-Treatment Indications in a Randomized, Double-Masked, Phase IIIb Study Comparing Ranibizumb Monotherapy With Ranibizumab + PDT Combination Therapy in Patients With Subfoveal Choroidal Neovascularisation

P. B. Henrich; K. B. Hatz; U. Schneider; B. Braun; S. Sacu; C. F. Pruente

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1904.

ARVO Annual Meeting Abstract April 2009

Comparing Ranibizumab Monotherapy and Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: 1-Year Fluoresceine Angiographic and OCT Results

K. B. Hatz; U. Schneider; B. Braun; P. B. Henrich; S. Sacu; G. Fuchsjaeger-Mayrl; C. F. Pruente

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1923.

ARVO Annual Meeting Abstract April 2009

Results of 20-Gauge and 23-Gauge Vitrectomy Technique in Patients With Retinal Detachment and Proliferative Vitreoretinopathy

T. Josifova; B. P. Henrich; U. Schneider

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4193.

ARVO Annual Meeting Abstract April 2009

A Randomized Double-masked Study Comparing Lucentis Monotherapy and PDT Combined With Lucentis Therapy in Patients With Exudative AMD: One Year Results for BCVA and Retreatment Frequency

C. Pruente; K. Hatz; P. B. Henrich; B. Braun; S. Sacu; U. Schneider

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5224.

ARVO Annual Meeting Abstract May 2008

Randomized Double-Masked Study Comparing Ranibzumab Monotherapy and PDT Combined With Ranibizumab in Patients With Exudative AMD: BCVA and Morphological Results

K. B. Hatz; U. Schneider; S. Sacu; B. Henrich; B. Braun; G. Fuchsjaeger; C. F. Pruente

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1170.

ARVO Annual Meeting Abstract May 2008

Evaluation of Re-Treatment Indications in a Randomized, Double-masked, Phase IIIb-Study Comparing Lucentis® Monotherapy versus PDT Combined With Lucentis® in Patients With Subfoveal Choroidal Neovascularisation

B. C. Braun; U. Schneider; B. Henrich; K. Hatz; G. Fuchsjäger-Mayrl; C. Pruente

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1172.

ARVO Annual Meeting Abstract May 2008

Macula-Off Retinal Detachment: A Matter of Time?

P. B. Henrich; T. Josifova; D. Klaessen; J.-O. Kono-Kono; U. Schneider

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5246.

ARVO Annual Meeting Abstract May 2007

Outcome of Ranibizumab (Lucentis®) Treatment in Patients With Choroidal Neovascularisation (CNV) Due to Age-Related Macular Degeneration (AMD) in a Clinical Routine Setting

B. C. Braun; P. Hasler; U. Schneider; C. Prünte

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1444.

ARVO Annual Meeting Abstract May 2005

Radial Optic Neurotomy in Central Vein Occlussion: Clinical Results of 107 Cases

J. Roider; H. Hasselbach; F. Rüfer; N. Feltgen; U. Schneider; S. Bopp; L. Hansen; H. Hoerauf; U. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4795.

Articles May 1997

Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.

PDF

U Felbor; D Doepner; U Schneider; E Zrenner; B H Weber
TAGS: body tissue, genes, macular disorders, metalloproteases
Invest. Ophthalmol. Vis. Sci.. 1997; 38(6):1054-1059.

Advertisement